Skip to content
TrialScanner

NCT03441100

TCR-engineered T Cells in Solid Tumors: IMA202-101

Phase 1CompletedIMTXLead

Registry record

Lead sponsor
Immatics US, Inc.
Conditions
Solid Tumor, Adult; Refractory Cancer; Recurrent Cancer; Cancer
Primary completion
Jun 17, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03441100 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03441100: TCR-engineered T Cells in... | TrialScanner